Formulation And Development Of Transdermal Patch Of Amlodipine Besylate Using Novel Polymers As Rate Controlling Membrane
Article Sidebar
Main Article Content
Abstract
This research study aims to formulate, prepare and evaluate transdermal drug delivery system for the purpose of controlled release of Amlodipine Bebesylate as a model drug using different polymers as a rate controlling membraneamlodipine undergoes first pass metabolism and also has easy permeability through skin therefore transdermal system of Amlodipine Bebesylate can be developed. The transdermal patches for the delivery were prepared by evaporation method i.e., solvent evaporation method. A matrix-type amlodipine besylate transdermal drug delivery system was prepared using novel polymers such as hydroxypropyl methylcellulose (HPMC) and sodium carboxymethylcellulose (SCMC) and Carbopol P 934 as a rate controlling or rate limiting membrane which delivers the drug or releases the therapeutic drugin controlled and a predetermined manner and rate. The formula for the transdermal patch was optimized using the experimental design. On the basis of the Data from drug release studies and the drug content the optimized batch was found to be F14 showing 80.1% of drug release and 95.62% of drug content. The patches were also evaluated forvarious evaluation parameters such as thickness uniformity,weight variation, moisture content determination, hygroscopicity &tensile strength.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Mishra AN, Jain NK. Transdermal drug delivery. Controlled and noval drug delivery system. CBS Publishers& distributers, 1st Edition 1997, Reprint 2012; 100-127.
Chein YW. Transdermal Controlled systemic Medication. Marcel Dekkar Inc. New York. 1987; 159-157.
Shirley MN. Compatibility and synergy of permeation enhancers with solvents, excipients and drugs in drug permeation enhancement. New York; Marcel Dekker; 1994: 91-106.
Ahmed T, Ashley S, Mitragotri S. Description of transdermal transport of hydrophilic solutes during low frequency Sonophorosis based on modified porous pathway model. Journal of pharmaceutical science. 1992; 2: 381-93.
Catherine L, Dujardin N, Preat V. Transdermal Delivery of macromolecules using skin Electroporation. Pharma Research. 2000; 17(1): 32-37.
Bramson J, Dayball, Evelegh C, Wan YH. Enabling topical immunization via microporation: A noval method for pain free and needle free delivery of adenovirus vaccines. Gene therapy. 2003; 10: 251-60.
Henry S, Mc Alliste D, Allen MG, Pausntz MR. Micro-fabricated micro-needles: A novel method to increase transdermal drug delivery. Journal of pharmaceutical sciences. 1998; 87: 922-25.
Lincy J, Kumar A, Samuel S. Formulation and evaluation of Amlodipine transdermal patches using ethyl cellulose. International research journal of pharmacy. 2013; 4(10): 84-88.
Eswaramma P, Karthikeyan M, Kumar Vinay N, Reddy Krishna Y. Formulation and evaluation of transdermal patch of Atenolol. International Journal of Comprehensive Pharmacy. 2010; 1(1): 1-5.
Selvam RP, Singh KA, Sivakumar T. Transdermal drug delivery systems for antihypertensive drugs - A review, International Journal of Pharmaceutical and biomedical research. 2010;1(1): 1-8.
Das A, Ghosh S, Day BK, Das S. A noval technique for treating the type 2 Diabetes by using multiple polymer complexes. International journal of pharmaceutical Research and Development. 2010; 9(2): 195-204.
Patel RP, Patel G, Formulation and evaluation of transdermal patch of Aceclofenac. International journal of drug delivery. 2009; 41-51.
Kumar PD, Swathi BS. Formulation and in-vitro characterisation of transdermal films for Metoprolol Tartarate. Asian journal of pharmaceutical and clinical research. 2013; 6(1): 146-148.
Mohammad A, Ehtheshamuddin M, Chand S, Hanifa, Sabreesh M, Kumar S G. Formulation and evaluation of transdermal patches of Atenolol. Advance Research in pharmaceuticals and Biologicals. 2011; 2(1): 109-119.
Barhate SD, Potdar MB. Formulation of transdermal patch of Carvedilol by using noval polymers. Pelagia Research library. 2011; 2(2): 185-189.
European pharmacopoeia 2005, Amlodipine monograph, Vol 01: 1491
Rowe CR, Sheskey JP, Quinn EM. Handbook of Pharmaceutical Excipients. 6th Edition. Published by the Pharmaceutical Press. 110-120,333-334.
Clarke’s Analysis of Drugs and Poisons, third edition, Pharmaceutical press; 2005:
Indian Pharmacopoeia. Volume I. 2007. New Delhi: Ministry of Health and Family Welfare, Government of India. 2007; Controller of Publication. 143.
Indian Pharmacopoeia. Volume II. 2007. New Delhi: Ministry of Health and Family Welfare, Government of India. 2007; Controller of Publication. 96-97.
Sheraz, M. A., Ahsan, S. F., Khan, M. F., Ahmed, S., & Ahmad, I. (2016). Formulations of Amlodipine: A Review. Journal of pharmaceutics, 2016, 8961621. https://doi.org/10.1155/2016/8961621
Palma-Gámiz J. L. High blood pressure and calcium antagonism. Cardiology. 1997;88(1):39–46. doi: 10.1159/000177461.
Lee H.-Y., Kang H.-J., Koo B.-K., et al. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison. Clinical Therapeutics. 2005;27(6):728–739. doi: 10.1016/j.clinthera.2005.06.011.
Sweetman S. C. Martindale: The Complete Drug Reference. 36th. London, UK: Royal Pharmaceutical Society; 2009.
Kapoor A., Mishra S.K., Verma D.K., Pandey P. Chemical penetration enhancers for transdermal drug delivery system. Journal of Drug Delivery and Therapeutics. 2018;8(5-s):62–66.
Mounika K., Reddy B.V., Reddy K.N. Formulation and evaluation of carvedilol transdermal patches with hydrophilic polymers. World Journal of Pharmaceutical Research. 2014;3(10):815–826.